• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌的病因及早期前列腺癌筛查的意义]

[Etiology of prostate cancer and significance of screening for early prostate cancer].

作者信息

Imai K, Fukabori Y, Yamanaka H

机构信息

Dept. of Urology, Gunma University School of Medicine, Japan.

出版信息

Gan To Kagaku Ryoho. 1996 Mar;23(4):403-6.

PMID:8678489
Abstract

The incidence and mortality rate of prostate cancer in Japan are lower than in Western countries. Though studies of migrating populations would suggest that dietary or environmental factors may influence the etiology of the disease. The Westernized lifestyle after the Second World War may have influenced the increasing incidence of this disease in Japan. The screening by prostate specific antigen (PSA) on an asymptomatic healthy population can detect early prostate cancer. It is expected that the mortality may be decreased through such a system. However, some scientists hesitate to perform an aggressive program of early detection because of the possibility of latent cancer detection, the difficulty of distinguishing between clinically important and unimportant cancer, a high false positive rate to detect early stage cancer, and the lack of well-executed randomized prospective studies. Current clinical studies of the prostate cancer have demonstrated that the unimportant cancer detection rate by PSA was less than 10%. When a 4.0 ng/ml PSA cut-off value is applied for early detection, the false positive rate is approximately 80%. It is important to make subjects examined by the screening program aware of its the meaning. However, there is not a complete and cost-effective diagnostic modality to detect early prostate cancer. Moreover, it is confirmed that radical prostatectomy improves survival, but it has not been confirmed to improve the mortality based on population. We propose that well-executed randomized studies by the end point of the survival, cancer death rate, cost effective, QOL and etc. are urgently needed.

摘要

日本前列腺癌的发病率和死亡率低于西方国家。尽管对移民人群的研究表明,饮食或环境因素可能会影响该疾病的病因。第二次世界大战后的西方化生活方式可能影响了日本这种疾病发病率的上升。对无症状健康人群进行前列腺特异性抗原(PSA)筛查可以检测出早期前列腺癌。预计通过这样的系统死亡率可能会降低。然而,一些科学家由于存在检测到潜在癌症的可能性、区分临床重要和不重要癌症的困难、检测早期癌症的高假阳性率以及缺乏精心实施的随机前瞻性研究,而对积极开展早期检测计划持犹豫态度。目前前列腺癌的临床研究表明,PSA检测出不重要癌症的比率低于10%。当将4.0 ng/ml的PSA临界值用于早期检测时,假阳性率约为80%。让参与筛查项目的受试者了解其意义很重要。然而,目前尚无完整且具有成本效益的早期前列腺癌诊断方法。此外,已证实根治性前列腺切除术可提高生存率,但尚未证实基于人群的死亡率会因此降低。我们建议迫切需要开展以生存率、癌症死亡率、成本效益、生活质量等为终点的精心实施的随机研究。

相似文献

1
[Etiology of prostate cancer and significance of screening for early prostate cancer].[前列腺癌的病因及早期前列腺癌筛查的意义]
Gan To Kagaku Ryoho. 1996 Mar;23(4):403-6.
2
[Characteristics of screening-detected prostate cancer on health checkup].[健康体检中筛查发现的前列腺癌的特征]
Gan To Kagaku Ryoho. 1998 Aug;25(10):1527-32.
3
[Adenocarcinoma of the prostate].前列腺腺癌
Cas Lek Cesk. 1998 Aug 31;137(17):515-21.
4
[Advancements in PSA-based screening for prostate cancer].[基于前列腺特异性抗原(PSA)的前列腺癌筛查进展]
Rinsho Byori. 2004 Jul;52(7):611-7.
5
Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).前列腺癌的检测:欧洲前列腺癌筛查随机研究(ERSPC)的影响
Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3.
6
Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).接受前列腺特异性抗原(PSA)筛查的老年男性前列腺癌患病率(诗里拉吉医院建院纪念日庆祝活动)
J Med Assoc Thai. 2006 Jan;89(1):37-42.
7
[Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma].
Schweiz Med Wochenschr. 1996 Nov 2;126(44):1881-90.
8
Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.日本筛查发现的前列腺癌中前列腺特异性抗原动力学
Urology. 2008 Nov;72(5):1111-5. doi: 10.1016/j.urology.2007.12.090. Epub 2008 Mar 17.
9
Should prostate-specific antigen screening be offered to asymptomatic men?是否应向无症状男性提供前列腺特异性抗原筛查?
Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64.
10
Diagnosis, management and screening of early localised prostate cancer.早期局限性前列腺癌的诊断、管理与筛查
Health Technol Assess. 1997;1(2):i, 1-96.